Log In
BCIQ
Print this Print this
 

BT-063

  Manage Alerts
Collapse Summary General Information
Company Biotest AG
DescriptionHumanized mAb targeting an undisclosed immune messenger substance
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard IndicationLupus
Indication DetailsTreat systemic lupus erythematosus (SLE)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today